Cargando…

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents

INTRODUCTION: Antidepressant discontinuation may cause withdrawal syndrome in some cases. However, evidence on this syndrome related to individual antidepressants is limited, as well as about individual risk factors for severe reactions. OBJECTIVES: To ascertain whether each individual antidepressan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gastaldon, C., Schoretsanitis, G., Arzenton, E., Raschi, E., Papola, D., Ostuzzi, G., Moretti, U., Seifritz, E., Kane, J. M., Trifirò, G., Barbui, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596361/ http://dx.doi.org/10.1192/j.eurpsy.2023.277

Ejemplares similares

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants
por: Gastaldon, C., et al.
Publicado: (2023)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
por: Gastaldon, C., et al.
Publicado: (2023)

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
por: Gastaldon, Chiara, et al.
Publicado: (2022)

Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market
por: Gastaldon, C., et al.
Publicado: (2021)

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis
por: Papola, D., et al.
Publicado: (2021)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Infections associated with clozapine: a pharmacovigilance study using VigiBase(®)
por: Chrétien, Basile, et al.
Publicado: (2023)

Predicting relapse after antidepressant withdrawal – a systematic review
por: Berwian, I. M., et al.
Publicado: (2017)

The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
por: Battini, Vera, et al.
Publicado: (2023)

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase(®) Spontaneous Reporting System
por: Noseda, Roberta, et al.
Publicado: (2022)

Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses
por: Papola, Davide, et al.
Publicado: (2020)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
por: Gatti, Milo, et al.
Publicado: (2021)

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials
por: Papola, Davide, et al.
Publicado: (2023)

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Hepatic disorders associated with the use of Ivermectin for SARS-CoV-2 infection in adults: a pharmacovigilance study in VigiBase
por: Oscanoa, Teodoro J., et al.
Publicado: (2022)

Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
por: Papola, Davide, et al.
Publicado: (2020)

Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
por: Todesco, B., et al.
Publicado: (2022)

Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications
por: Alomar, Muaed, et al.
Publicado: (2019)

Renal Safety Profile of BCR-ABL Tyrosine Kinase Inhibitors in a Real-Life Setting: A Study Based on Vigibase(®), the WHO Pharmacovigilance Database
por: Cellier, Morgane, et al.
Publicado: (2023)

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
por: Sultana, Janet, et al.
Publicado: (2020)

Antidepressant withdrawal – the tide is finally turning
por: Hengartner, Michael P., et al.
Publicado: (2019)

In Silico Pharmacogenetics CYP2D6 Study Focused on the Pharmacovigilance of Herbal Antidepressants
por: Don, Charleen G., et al.
Publicado: (2020)

Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase(®)
por: Chandler, Rebecca E., et al.
Publicado: (2016)

Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
por: Papola, Davide, et al.
Publicado: (2023)

Liver Injury with Nintedanib: A Pharmacovigilance–Pharmacokinetic Appraisal
por: Raschi, Emanuel, et al.
Publicado: (2022)

VigiAccess: Promoting public access to VigiBase
por: Shankar, Pathiyil Ravi
Publicado: (2016)

Tricyclic Antidepressant Withdrawal - A Case Report
por: Rajendra, P.N., et al.
Publicado: (1987)

Conversations with clients about antidepressant withdrawal and discontinuation
por: Karter, Justin M.
Publicado: (2020)

Antidepressant-withdrawal mania - a case report
por: Magalhães, M., et al.
Publicado: (2021)

Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance
por: Raschi, Emanuel, et al.
Publicado: (2020)

Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial
por: Turrini, G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_742khfjkkkqpojm7qcamm1oohi